Huron Consulting Group, Inc.
Robbins Umeda LLP Announces an Investigation of Huron Consulting Group Inc.
Robbins Umeda LLP is investigating possible breaches of fiduciary duty and other violations of the law by certain officers and directors at Huron Consulting Group Inc. (NASDAQ: HURN). Concerned shareholders who would like more information about their rights and potential remedies can complete the form below and we will contact you directly. You can also contact attorney Gregory E. Del Gaizo at (800) 350-6003.
Robbins Umeda LLP’s investigation focuses on whether members of the board of directors at Huron breached their fiduciary duties to shareholders by engaging in a scheme to defraud the federal Medicare program and New York state Medicaid program. In particular, Huron has allegedly submitted reimbursement claims for services that did not conform with Medicare and Medicaid regulations. Robbins Umeda LLP is also investigating whether the officers and directors of the company not only exposed Huron to significant liability, but also falsely represented that Huron was operating in compliance with all applicable laws and regulations to the investing public.
As a result of these allegations, the officers and directors may have caused Huron to report net sales and accounts receivable that were artificially inflated as they included proceeds of the Medicare/Medicaid fraud. In fact, according to a federal whistleblower lawsuit that recently defeated a motion to dismiss, Huron even kept a second set of books that kept track of the fraud. As a result of these activities, Huron is named as a defendant in a whistleblower lawsuit, exposing the company to over $100 million in potential costs to settle allegations of wrongdoing involving continued Medicare and Medicaid fraud.
Robbins Umeda LLP highlights that Huron shareholders have the option to file a derivative action to hold those officers and directors accountable for damaging the company. Remedies commonly sought in derivative actions include corporate governance reforms designed to prevent future misconduct, removal of officers or directors whose misconduct injured the corporation, and monetary payments in the form of damages and disgorgement of ill-gotten gains.
Robbins Umeda LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.